baber/WOPTO huggingface dataset:
Patent EP-4024016-A1 (EP)
Inventor: KNOLL MATTHEW
IPC: G01J3/02
Filed: 2020-12-30
Abstract: A color measurement instrument for measuring colors of areas of interest of a target object includes a spectral engine, a color camera, a display, and a processor. The spectral engine has a first field of view. The camera has a second field of view, the second field of view being larger than the first field of view and encompassing the first field of view. The processor is coupled to the spectral engine, camera and display, and configured with instructions that, when executed, cause the processor to display a live view of the second field of view on the display with a representation of the location of the first field of view superimposed on the displayed live view. When the color measurement instrument is placed near the target object, the live view on the display includes one or more of the areas of interest on the target object.
Patent EP-3872440-A1 (EP)
IPC: F42B33/14
Filed: 2020-02-27
Abstract: This invention relates to a improvements relating to munitions, specifically to coating small arms ammunition with decoppering agents, as a replacement in lead free ammunition. There is a method of manufacturing a coated metallic projectile for a rifled barrel, comprising; providing a metallic projectile cup with a coating of a decoppering agent located thereon, to provide a coated metallic projectile cup; causing the coated metallic projectile cup to be drawn through a plurality of dies to form a drawn coated metallic projectile.
Patent EP-3984957-A1 (EP)
Title: Calcium carbonate particulate material with low content of water soluble magnesium ions
Inventor: BRIAND AMANDINE
IPC: C01F11/18
Filed: 2020-10-15
Abstract: The present disclosure relates to a calcium carbonate particulate material comprising less than about 200 ppm of water soluble magnesium ions based on the total amount of the calcium carbonate particulate material, wherein the amount of water soluble magnesium ions is determined using the method described herein. The present disclosure further relates to methods for preparing the calcium carbonate particulate materials according to the invention and to paint compositions comprising the calcium carbonate particulate materials according to the present disclosure or the calcium carbonate particulate materials obtainable by the methods according to the present disclosure.
Patent EP-3810868-A1 (EP)
Inventor: PETERSEN FRANK
IPC: E04F13/076
Filed: 2020-01-27
Abstract: Die Erfindung betrifft ein Belagselement (1), vorgesehen zur Verwendung als Boden-, Wand- und/oder Deckenbelagselement für einen Boden-, Wand- und/oder Deckenbelag, mit wenigstens einer Trägerplatte (2) und wenigstens einer Funktionsschicht (3), wobei die Trägerplatte (2) eine einer Nutzseite (4) zugewandte Oberseite (5) und eine der Oberseite (5) gegenüberliegende, dem Untergrund (6) zugewandte Unterseite (7) aufweist. Erfindungsgemäß ist vorgesehen, dass die Funktionsschicht (3) unterhalb der Trägerplatte (2) vorgesehen ist und dass die Funktionsschicht (3) derart ausgebildet ist, dass sie an wenigstens einer Seite (8), insbesondere an wenigstens einer Längsseite (9), im Einbauzustand über den Seitenrand (10) der Seite (8), insbesondere der Längsseite (9), übersteht.
Patent EP-3915140-A1 (EP)
Inventor: MCCORMACK MARK THOMAS
IPC: H01L21/66
Filed: 2020-01-04
Abstract: A method for validating that an integrated circuit die is not susceptible to a conductive metallic ion diffusion defect is disclosed. A test component is applied to a backside surface of the integrated circuit die to form a test assembly. The test component includes a conductive metal layer and a transport media layer for facilitating diffusion of conductive metallic ions. The test assembly is heated at a thermal activation temperature. The integrated circuit die is computer validated to determine whether or not the integrated circuit die has the conductive metallic ion diffusion defect.
Patent EP-3917486-A1 (EP)
Inventor: YEDGAR AVIAD
IPC: A61J1/20
Filed: 2020-01-31
Abstract: L'invention concerne un dispositif de transfert de liquide. Le dispositif comprend un corps de raccord comprenant une partie en saillie définissant une languette et un orifice IV agencés au niveau d'une première extrémité du corps de raccord, l'orifice IV comprenant un élément de raccordement allongé en saillie à partir de celui-ci et définissant une découpe. La partie en saillie est conçue pour être reçue par l'élément de raccordement allongé et la languette est conçue pour s'accoupler avec la découpe de façon à fixer en rotation l'orifice IV par rapport au corps de raccord.
Patent EP-3884590-A1 (EP)
Inventor: STAUFFER ERIK
IPC: H04B7/06
Filed: 2020-01-10
Abstract: The systems, methods, and techniques described in this disclosure allow different wireless systems that operate in accordance with different Radio Access Technologies (RATs) to coexist within a same frequency domain with minimal (if any) inter-RAT interference. Specifically, the described techniques allocate a respective, mutually-exclusive portion of a plurality of Space-Time-Frequency (STF) resources for use in communicating in accordance with each different RAT. For example, mutually-exclusive portions of spatial domain resources, time domain resources, and/or frequency domain resources may be respectively allocated for exclusive use by different RATs. A centralized, third-party controller (120) may perform the allocations, or the allocations may be cooperatively arrived at between systems supporting different RATs, e.g., in a peer-to-peer manner. STF resource allocations may be static and/or dynamic over time, and STF resources may be uniquely identified by respective resource identifiers.
Patent EP-3931194-A1 (EP)
Inventor: SIKERVAR VIKAS
IPC: C07D471/04
Filed: 2020-02-28
Abstract: L'invention concerne des composés de formule (1), dans laquelle les substituants sont tels que définis dans la revendication 1. La présente invention concerne en outre des compositions agrochimiques comprenant les composés de formule (I), la préparation de ces compositions, et l'utilisation des composés ou compositions en agriculture ou en horticulture pour combattre, prévenir ou lutter contre des animaux nuisibles, notamment des arthropodes et en particulier des insectes, des mollusques, des nématodes ou des représentants de l'ordre des acariens.
Patent EP-3934756-A1 (EP)
Inventor: BLANC JEAN-BAPTISTE
IPC: C07D401/14
Filed: 2020-03-06
Abstract: The invention provides novel imidazole pyrazole derivatives having the general formula (I), and pharmaceutically acceptable salts thereof, wherein X1, RA and R3 to R7 are as described herein: (I) Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.
Patent EP-3931322-A1 (EP)
Inventor: DING BEIBEI
IPC: C12N15/11
Filed: 2020-02-27
Abstract: There is disclosed an improved, safer and commercially efficient process for developing genetically engineered cells. More specifically, there is disclosed a process comprises introducing a donor DNA construct, a guide RNA, and an RNA-guided nuclease with the host cells to he transfected; and introducing the three components into the host cell. There is further disclosed a donor DNA construct designed for inserting a CAR (chimeric antigen receptor) into a defined genomic site of a host cell. Further, the present disclosure provides a host cell transfected with a CAR that lacks viral vectors that can present a safety concern. The disclosure provides for more efficient and more cost-effective process for engineering T cells to express CAR constructs.
Patent EP-3959177-A1 (EP)
Title: Coated substrate and process of preparation
Inventor: BROWN JACK
IPC: C02F103/04
Filed: 2020-03-27
Abstract: A water purification apparatus able to provide at least three dispense purified water streams is described. The apparatus comprises: a first water purification station to provide a first internal purified water stream; a valve able to select either a first dispense purified water stream or a first continuing water stream or both; an internal reservoir to receive the first continuing water stream to hold a volume of second purified water, and to provide a second internal purified water stream, a second valve able to dispense the second dispense purified water stream from the water purification apparatus; a second water purification station able to receive the second internal purified water and able to provide a third internal purified water stream; a third valve able to select from the third internal purified water stream either a third dispense purified water stream, or a third continuing water stream, or both; a recirculation loop able to return the third continuing water stream into the internal reservoir; and a pump able to pump the second internal purified water stream from the internal reservoir around the recirculation loop.
Patent EP-4128268-A1 (EP)
Title: A method for inferring epileptogenicity of a brain region
Inventor: JIRSA VIKTOR
IPC: G16H50/20
Filed: 2020-04-03
Abstract: The invention relates to a method for inferring epileptogenicity of a brain region that is not observed as recruited or is not observed as not recruited, in a seizure activity of an epileptic patient brain, comprising the steps of: providing a computerized model modelling various regions of a primate brain and connectivity between said regions; providing said computerized model with a model able to reproduce an epileptic seizure dynamic in the primate brain; providing structural data of the epileptic patient brain and personalizing the computerized model using said structural data in order to obtain a virtual epileptic patient (VEP) brain model; translating a state-space representation of the virtual epileptic patient (VEP) brain model into a probabilistic programming language (PPL) using probabilistic state transitions in order to obtain a probabilistic virtual epileptic patient brain model (BVEP); and acquiring electro- or magneto-encephalographic data of the patient brain and fitting the probabilistic virtual epileptic patient brain model against said data in order to infer the epileptogenicity of said brain region that is not observed.
Patent EP-3949625-A1 (EP)
Title: Channel occupancy time (cot) structure indication
Inventor: SUN JING
IPC: H04W72/12
Filed: 2020-03-26
Abstract: This disclosure provides systems, methods and apparatus for a user equipment (UE), operating in a shared spectrum in a connected state or an idle state, to receive a channel occupancy time structure information (COT-SI) which includes one or more of a COT duration, a COT end symbol, and a COT pause indication, in addition to slot format indication for one or more slots. Some aspects described herein define a hierarchical approach to COT structure information (COT-SI) signaling. For example, a UE may be configured with a set of short COT tables using remaining minimum system information (RMSI) signaling and may receive concatenation of COT-SI signaling identifying index values in a control channel corresponding to one or more of the set of COT tables. Based on receiving COT-SI signaling, the UE may communicate in accordance with an occurrence of a COT.
Patent EP-3949237-A1 (EP)
Inventor: FAKOORIAN SEYED ALI AKBAR
IPC: H04L5/00
Filed: 2020-03-30
Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a user equipment may receive an indication associated with processing a communication, wherein the indication includes at least one of a physical downlink control channel (PDCCH)-based indication and a sequence-based indication, and wherein the UE is configured to receive PDCCH-based indications and sequence-based indications; and processing the communication based at least in part on the indication. Numerous other aspects are provided.
Patent EP-3946626-A1 (EP)
Title: Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
Inventor: ARATHOON WILLIAM ROBERT
IPC: A61K39/395
Filed: 2020-04-01
Abstract: Provided are multi-specific antibodies that target both a cellular efflux pump and a cancer-associated antigen as well as pharmaceutical compositions, nucleic acids, recombinant expression vectors, cells, and kits that include or encode such multi-specific antibodies. Methods of treating a subject for a cancer that include administering to the subject a multi-specific antibody that targets both a cellular efflux pump and a cancer-associated antigen are also provided. Provided as well are methods of generating the described multi- specific antibodies and reagents related thereto, including genetically modified cell lines useful in the subject methods and methods of making such genetically modified cell lines.
Patent EP-3952954-A1 (EP)
Inventor: PAK JANICE
IPC: A61M5/168
Filed: 2020-04-07
Abstract: Roller clamps are described herein. A roller clamp includes a housing, a roller wheel, and a locking device. The housing includes a first wall and a second wall, wherein the first wall and the second wall are spaced apart to define a longitudinal channel therebetween, the housing including an upper opening and a lower opening configured to allow a tubing to pass through the longitudinal channel. The roller wheel is disposed at least partially within the longitudinal channel and configured to engage the tubing, the roller wheel including a plurality of teeth extending from an outer surface of the roller wheel, wherein a longitudinal position of the roller wheel relative to the channel adjusts a flow rate through the tubing. The locking device is releasably engaged to the housing and the roller wheel, wherein the locking device prevents movement of the roller wheel from the longitudinal position.
Patent EP-4139054-A1 (EP)
Inventor: TIEDTKE HANS-JÜRGEN
IPC: G01N21/01
Filed: 2020-04-21
Abstract: L'invention concerne un dispositif de pipetage pour le traitement d'un échantillon de fluide (71) comprenant un élément de réception (11) et une pointe de pipette (12) agencée de manière amovible sur l'élément de réception (11) ; un élément de déplacement (14) relié fluidiquement à la pointe de pipette (12) pour générer un écoulement pour recevoir et/ou évacuer l'échantillon de fluide (71). Le dispositif de pipetage (1) comprend une extension optiquement transparente (13) laquelle extension (13) est agencée de manière amovible sur la pointe de pipette (12) de telle sorte que l'extension (13) est reliée fluidiquement à l'élément de déplacement (14) par l'intermédiaire de la pointe de pipette (12), de manière telle que l'échantillon de fluide peut être reçu dans l'extension (13) et/ou évacué à partir de l'extension (13) par l'intermédiaire de l'écoulement qui peut être généré par l'élément de déplacement (14). Le dispositif de pipetage est de préférence utilisé dans un système de mesure optique.
Patent EP-3955966-A1 (EP)
Inventor: RAKHADE SANJAY
IPC: A61K47/64
Filed: 2020-04-16
Abstract: Methods for treating Duchenne muscular dystrophy using conjugates of cell penetrating peptides to antisense oligonucleotide that induce exon skipping in the human dystrophin gene. In one embodiment, the cell penetrating peptide is an arginine-rich peptide comprising six contiguous arginine residues and the antisense oligonucleotide is eteplirsen, golodirsen or casimersen.
Patent EP-3953340-A1 (EP)
Inventor: BHUJADE PARAS RAYBHAN
IPC: C07D491/10
Filed: 2020-04-07
Abstract: The present invention discloses a compound of formula (I), wherein, R 1 , L 1 ,A, k, L 2 , W, L 4 , R 5 , R 8  and R 9  are as defined in the detailed description. The present invention further discloses a process for preparing the compound of formula (I).
Patent EP-3962517-A1 (EP)
Title: Scar prevention and/or treatment
Inventor: DANIELS ROBERT
IPC: A61K38/39
Filed: 2020-05-02
Abstract: The disclosure relates to methods of treating and/or preventing scarring that would otherwise result from an incision to an area of skin. The methods comprise administering a composition comprising tropoelastin to an area of skin that is to receive an incision and/or after the incision. It is also contemplated that the compositions may reduce scar discoloration. Methods of preventing or reducing keloid re-occurrence are also provided.
Patent EP-3959859-A1 (EP)
Title: Improvements in the transmission of data or messages on board a vehicle using a some/ip communication protocol
Inventor: RISSO FULVIO
IPC: H04L29/06
Filed: 2020-04-23
Abstract: A method is described for the transmission of messages on a communications network on board a vehicle between an entity requesting a service instance and an entity offering a service instance by means of the SOME/IP communication protocol, which comprises: (a) a step of mutual authentication between the requesting entity and the offering entity in view of a communication associated with a service instance, including (i) verifying the existence and mutual validity of a pre-as signed certificate of the requesting entity and the offering entity, which authorizes its access to the service instance, and (ii) verifying that the security level at which the service is offered by the offering entity is not lower than the minimum security level pre-assigned to the service at the requesting entity and at the offering entity; and (b) transmitting at least one communication message associated with a service instance from the offering entity to the requesting entity and vice versa if the certificate verification and security level verification are successful.
Patent EP-3972563-A1 (EP)
Inventor: DEBOTTON NIR
IPC: A61K9/00
Filed: 2020-05-17
Abstract: The present disclosure provides functional fibrous material comprising fibers associated with hydrogel containing micro-flakes. The present disclosure also provides a method of forming hydrogel micro-flakes having embedded therein at least one microorganism and a method of preparing functional fibrous material, both methods comprise a step of subjecting a mixture of hydrogel and microbial material to high shear forces to form micro-flakes comprising the hydrogel with at least one microorganism embedded therein. Further provided is a method of treatment of a target comprising contacting the target with the disclosed functional fibrous material as well as the micro¬ flakes disclosed herein.
Patent EP-3956299-A1 (EP)
Inventor: FU JIPING
IPC: C07C255/54
Filed: 2020-04-16
Abstract: The present disclosure provides certain tetrahydro-lH-cyclopenta[cd]indene compounds that are Hypoxia Inducible Factor 2α (HIF-2α) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of HIF-2α. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Patent EP-4026238-A1 (EP)
Inventor: KLEIN MARKUS
IPC: H02M1/36
Filed: 2020-07-07
Abstract: The voltage clamp circuit (10) as seen in figure (2), is adapted to clamp, voltage of an energy limited signal. The voltage clamp circuit (10) comprising a semiconductor component (12) electrically connected to a source (14), a capacitive component (16) electrically connected between one end of the semiconductor component (12) and a ground terminal and a precharging circuit electrically connected between one of said semiconductor component and a voltage supply line.
Patent EP-3820643-A1 (EP)
Title: Device for thermally joining at least one workpiece, comprising a torch and an extraction unit
Inventor: ROSE SASCHA
IPC: B23K9/095
Filed: 2020-07-07
Abstract: The invention relates to a device (10) for thermally joining workpieces, comprising a torch (1) and an extraction unit (2) for extracting fumes that are produced during welding, cutting or soldering processes. According to the invention, at least one sensor means (3) is provided for determining the position and/or position changes of the torch (1) and/or a reference point in the area relative to a reference position of the torch (1) and/or of the workpiece to be processed, in such a way that a volume flow of the extraction unit (2) acting on the torch (1) can be influenced according to the determined position and/or position change of the torch (1).
Patent EP-3908667-A1 (EP)
Inventor: FLASINSKI STANISLAW
IPC: C12N15/90
Filed: 2020-01-09
Abstract: L'invention concerne des molécules d'ADN de recombinaison et des constructions, ainsi que leurs séquences nucléotidiques, utiles pour moduler l'expression génique dans des plantes. L'invention concerne également des plantes transgéniques, des cellules végétales, des parties de plantes, et des graines comprenant les molécules d'ADN de recombinaison liées de manière fonctionnelle à des molécules d'ADN transcriptibles hétérologues, ainsi que leurs procédés d'utilisation.
Patent EP-3880893-A1 (EP)
Inventor: DULBERG SHARON
IPC: E03B3/28
Filed: 2020-01-08
Abstract: L'invention concerne un AWG ayant des améliorations conçues pour réduire le bruit, améliorer l'écoulement d'air uniforme à travers l'évaporateur de l'AWG et réduire la consommation d'énergie. Dans un mode de réalisation, l'AWG comprend une entrée d'air située dans l'une des parois latérales de l'enceinte et une soufflante située à proximité de la sortie d'air au niveau de la paroi inférieure de l'enceinte.
Patent EP-3976236-A1 (EP)
Inventor: BRUHN TIMOTHY M
IPC: B01D69/12
Filed: 2020-05-30
Abstract: A biocompatible membrane composite including a first layer (cell impermeable layer), a second layer (a mitigation layer), and a third layer (a vascularization layer) is provided. The mitigation layer may be positioned between the cell impermeable layer and the vascularization layer In some embodiments, the cell impermeable layer and the mitigation layer are intimately bonded to form a composite layer having a tight/open structure. A reinforcing component may optionally be positioned on either side of the biocompatible membrane composite or within the biocompatible membrane composite to provide support to and prevent distortion of the membrane composite. The biocompatible membrane composite may be used in or to form a device for encapsulating biological entities, including, but not limited to, pancreatic lineage type cells such as pancreatic progenitors.
Patent EP-4009921-A1 (EP)
Inventor: BÜCHERT MICHAEL
IPC: A61F2/82
Filed: 2020-07-21
Abstract: Die Erfindung betrifft eine medizinische Vorrichtung zur Behandlung von Aneurysmen, insbesondere Stent, mit einer komprimierbaren und expandierbaren Gitterstruktur (10) aus Gitterelementen (11, 12, 13, 14), die wenigstens einen geschlossenen Zellenring (34) aufweist, der höchstens (12), insbesondere höchstens (10), insbesondere höchstens (8), insbesondere höchstens (6), in einer Umfangsrichtung der Gitterstruktur (10) unmittelbar benachbarte Zellen (30) umfasst, wobei die Gitterstruktur (10) zumindest abschnittsweise mit einer Abdeckung (40) aus einem elektrogesponnenen Gewebe versehen ist, das unregelmäßig große Poren (41) aufweist, wobei die Abdeckung (40) auf einer 10 Fläche von 100.000 µm² mindestens (10) Poren (41) umfasst, die eine Größe von mindestens 15 µm² aufweisen, und wobei die Abdeckung (40) eine biokompatible, insbesondere antithrombogene und/oder endothelialisierungsfördernde, Beschichtung (45) aufweist.
Patent EP-4000066-A1 (EP)
Inventor: Venkatesh Ganesh
IPC: G06N3/04
Filed: 2020-07-09
Abstract: Disclosed herein includes a system, a method, and a device for performing a convolution on data of a current layer of a neural network, including a plurality of channels arranged in a first order and partitioned into a plurality of first partitions according to the first order. Each first partition includes a result of a convolution on a corresponding partition of channels in data of a previous layer of the neural network. The device shifts the plurality of channels arranged in the first order to a second order, partition the shifted plurality of channels into a plurality of second partitions, according to the second order. For each of the plurality of second partitions, the device performs a convolution on channels of the shifted plurality of channels that are in the corresponding second partition.